Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04344002
  4. Details
NCT04344002 Clinical Trial

LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)

Covid-19 Clinical Trial

— GRAVID  

Official title:
Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04344002
Other study ID # GECP 20/02_GRAVID
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 21, 2020
Est. completion date October 6, 2021

Study information
Verified date June 2022
Source Spanish Lung Cancer Group
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order to collect clinical data for the research. It will also include I on the care organization or the perception of the patient and their family members. The final stage will consist on retrospective data collection from patients. So, it is a retrospective study data collection, preceded by prospective data registry.

Recruitment information / eligibility
Status Completed
Enrollment 886
Est. completion date October 6, 2021
Est. primary completion date October 6, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients diagnosed with lung cancer - Patients who have contracted COVID-19 infection Exclusion Criteria: - Patients diagnosed with lung cancer but no confirmation of COVID-19 infection.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Spain Hospital Universitario Fundación Alcorcón Alcorcón Madrid
Spain H. Gen. Universitario Alicante Alicante
Spain Hospital Universitario de La Ribera Alzira Valencia
Spain Hospital Ntra. Sra. Sónsoles Ávila
Spain Hospital Universitari Germans Trias i Pujol Badalona Barcelona
Spain Hospital de Cruces Baracaldo Vizcaya
Spain H. Duran i Reynals-ICO Barcelona
Spain H. Universitario Quirón Dexeus Barcelona
Spain Hospital Clínic de Barcelona Barcelona
Spain Hospital de la Santa Creu i Sant Pau Barcelona
Spain Hospital del Mar Barcelona
Spain H. Clínica Benidorm Benidorm Alicante
Spain Hospital de Basurto Bilbao Vizcaya
Spain Hospital Universitario de Puerto Real Cádiz
Spain Hospital La Mancha Centro Ciudad Real
Spain Hospital Virgen de la Luz Cuenca
Spain Hospital de Elche Elche Alicante
Spain Hospital General Universitario de Elda Elda Alicante
Spain Cetir Centre Mèdic Esplugues De Llobregat Barcelona
Spain Complejo Hospitalario Universitario de Ferrol Ferrol A Coruña
Spain Hospital Universitario de Galdakao Galdakao Bizkaia
Spain Hospital Dr. Josep Trueta Girona
Spain Hospital Universitario Virgen de las Nieves Granada
Spain Hospital General de Granollers Granollers Barcelona
Spain Hospital de Guadalajara Guadalajara
Spain Complejo Hospitalario de la Coruña La Coruña Coruña
Spain H. Universitario de Canarias La Laguna Tenerife
Spain H. Insular de Gran Canarias Las Palmas De Gran Canaria Gran Canarias
Spain Hospital Severo Ochoa Leganés Madrid
Spain Complejo Asistencial Universitario de León León
Spain Hospital San Millan Y San Pedro Logroño
Spain Hospital San Pedro Logroño La Rioja
Spain Hospital Universitario Lucus Augusti Lugo
Spain Fundación Jimenez Diaz Madrid
Spain H.U. Puerta de Hierro Madrid
Spain Hospital 12 de Octubre Madrid
Spain Hospital Clínico San Carlos Madrid
Spain Hospital de Sanchinarro Madrid
Spain Hospital General Universitario Gregorio Marañón Madrid
Spain Hospital Universitario de Fuenlabrada Madrid
Spain Hospital Universitario del Henares Madrid
Spain Hospital Universitario Infanta Leonor Madrid
Spain Hospital Universitario Infanta Sofía Madrid
Spain MD Anderson Madrid
Spain Hospital Carlos Haya Málaga
Spain Hospital de Manacor Manacor Mallorca
Spain Hospital de Manises Manises Valencia
Spain Hospital Costa del Sol Marbella Málaga
Spain Hospital Universitario de Móstoles Móstoles Madrid
Spain Hospital General Universitario Morales Meseguer Murcia
Spain Hospital Santa María Naí Ourense
Spain H. Son Llàtzer Palma de Mallorca
Spain Hospital Son Espases Palma de Mallorca
Spain Clínica Universidad de Navarra Pamplona Navarra
Spain Clínica Universitaria de Navarra Pamplona Navarra
Spain Complejo Hospitalario de Navarra Pamplona Navarra
Spain Hospital Sant Joan de Reus Reus Tarragona
Spain Hospital Clinico de Salamanca Salamanca
Spain Hospital Instituto Onkologikoa San Sebastián País Vasco
Spain Hospital General de Segovia Segovia
Spain Hospital Virgen del Rocío Sevilla
Spain Hospital Sant Pau i Santa Tecla Tarragona
Spain Hospital universitario Nuestra Señora Candelaria Tenerife
Spain Hospital de Torrevieja Torrevieja Alicante
Spain Hospital Verge de la Cinta Tortosa Tarragona
Spain H. General U. de Valencia Valencia
Spain Hospital Arnau de Vilanova Valencia
Spain Hospital Clínico Universitario de Valencia Valencia
Spain Hospital Dr. Peset Valencia
Spain Hospital Politècnic i Universitari La Fe Valencia
Spain Hospital Universitario Dr. Peset Valencia
Spain Instituto Valenciano de Oncología Valencia
Spain Hospital Clínico Universitario de Valladolid Valladolid
Spain Hospital Universitario de Áraba Vitoria Áraba
Spain H. Miguel Servet Zaragoza

Sponsors (1)
Lead Sponsor Collaborator
Spanish Lung Cancer Group

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Clinical data of lung cancer patients with COVID-19 diagnoses Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as clinical data. From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
Primary Diagnosis data Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as data about diagnosis From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
Primary Treatments received Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as treatments received From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
Primary Prognostic factors Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as prognostic factors. From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

External Links